DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Introducing: Copay Accumulator Threat Assessor

Real world claims data, lives information and market research has come together to provide the most comprehensive copay accumulator database available in an easy to use dashboard. Get deep analysis on copay benefit design, understand business impact and gain informed, actionable insights.

 

Market Problem

 

  • Copay Accumulator benefit designs no longer allow coupon assistance provided by pharma to be applied toward patient deductibles. This is causing product shifting and therapy abandonment leading to increased cost, loss of market share and decreased margins.

DRG’s Copay Accumulator Solution

 

  • Through the combination of real world claims data, lives information and market research, DRG’s solution provides an interactive dashboard and insights model enabling our clients to…
    • Quantify the risk and impacts associated with these benefit designs
    • Assess individual therapy class and drug level exposure
    • Geographically identify the prevalence of lives within these programs by insurer/plan
    • Provide strategic guidance and solutioning pathways

Gauge the Impact of Copay Accumulator Programs

 

Understand

  • Gain a deep understanding of the market landscape
  • Identify the key players within the market deploying these benefit designs

Quantify

  • Assess the financial impacts by individual therapy class and drug level
  • Identify the prevalence of lives by insurer/plan and geographic region

Strategize, implement & measure

  • Develop comprehensive data-driven strategies
  • Deploy strategic initiatives to minimize financial & market share impacts

Product breakdown

 

DRG offers a truly unique combination of data and insights with at-a-glance views of:

  • THREAT ASSESSMENT – RWD supported insights on impacts by therapy class, drug and geographical region.
  • DRUG ANALYSIS – Assess drug-level risk, financial impacts, and compare your drug with competing therapies.
  • COPAY ASSISTANCE UTILIZATION TRACKER – Detail at the national and state levels; By therapy area and PBM.
  • PBM ENROLLMENT OVERVIEW – Includes number of potentially impacted patients, and views on high-risk, high-deductible health plans.
  • LEGISLATION – Key state level policies and regulations.